5 Cheap Pharmaceutical Stocks For 2021

3. Evolus, Inc. (NASDAQ: EOLS)

Number of Hedge Fund Holders: 10

Evolus, Inc. (NASDAQ: EOLS) is a California-based firm that deals in medical aesthetic products for physicians and their patients. The products of the firm include Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The firm also offers regulatory management services. It was founded in 2012 and is placed third on our list of 10 cheap pharmaceutical stocks for 2021. 

The market cap of the company is over $500 million and it posted a revenue of more than $20 million in the fourth quarter of 2020, up almost $13 million to the preceding quarter. The 52-week share price range of the firm is $17.3-$2.8. Earlier today, the shares were trading at $11.2. In March, the company announced that it had reached an open market sales agreement with SVB Leerink for $75 million worth of common stock. North Carolina-based Truist International had earlier downgraded Evolus rating from a Buy to Hold after an IP settlement by the firm.

AWH Capital currently holds 174,500 shares of EOLS that amounts $586,000. EOLS occupies 0.58% of AWH Capital’s total portfolio.